Skip to main content
. Author manuscript; available in PMC: 2015 Oct 8.
Published in final edited form as: Breast Cancer Res Treat. 2012 May 1;134(1):345–352. doi: 10.1007/s10549-012-2071-z

Table 2.

Efficacy

Best response No. of patients (%)
Partial response 6 (9.5 %)
Stable disease 14 (22.2 %)
Progression disease 37 (58.7 %)
Nonevaluable 6 (9.5 %)